Galera Therapeutics Inc (GRTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2019 | 12-2018 | 12-2017 | 12-2006 | 12-2005 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 18,356 | 14,811 | 6,169 | N/A | N/A |
| Marketable Securities | 93,934 | 66,706 | 8,011 | N/A | N/A |
| Receivables | N/A | 870 | 507 | N/A | N/A |
| TOTAL | $117,570 | $83,852 | $15,166 | $N/A | $N/A |
| Non-Current Assets | |||||
| PPE Net | 934 | 568 | 325 | N/A | N/A |
| Intangibles | 3,139 | 3,139 | 3,139 | 0 | 0 |
| Other Non-Current Assets | 1,733 | 497 | 242 | 0 | 0 |
| TOTAL | $5,806 | $4,204 | $3,706 | $N/A | $N/A |
| Total Assets | $123,376 | $88,056 | $18,872 | $N/A | $N/A |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 3,945 | 3,867 | 2,257 | 0 | 0 |
| Accrued Expenses | 5,452 | 2,577 | 2,037 | N/A | N/A |
| TOTAL | $9,694 | $6,444 | $4,294 | $N/A | $N/A |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 43,785 | 186,122 | 90,148 | 0 | 0 |
| TOTAL | $44,074 | $186,432 | $90,683 | $N/A | $N/A |
| Total Liabilities | $53,768 | $192,876 | $94,977 | $N/A | $N/A |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 24,820 | N/A | N/A | N/A | N/A |
| Common Shares | 25 | N/A | N/A | N/A | N/A |
| Retained earnings | -161,350 | -104,823 | -76,102 | N/A | N/A |
| Other shareholders' equity | 38 | 3 | -3 | 0 | 0 |
| TOTAL | $69,608 | $-104,820 | $-76,105 | $N/A | $N/A |
| Total Liabilities And Equity | $123,376 | $88,056 | $18,872 | $0 | $0 |